StockGlow

Ionis Pharmaceuticals, Inc. (ISI.F)

Ionis Pharmaceuticals, Inc., a commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

46.56-0.03%Healthcare
Compare ISI.F with
StockGlow Score
15
Bearish
BearishBullish
1 year ago+25.4%

The outlook

Ionis Pharmaceuticals, Inc. currently reads as bearish based on below its 50- & 200-day averages, 30% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range30% of the way from its 52-week low to high
Market cap
$7.74B
52-wk high
75.00
52-wk low
34.62
50-day avg
61.12
200-day avg
64.63
Trailing P/E
—

Similar stocks

FTD.SGFinancière de Tubize SA$190.20-10.70%FTD.FFinancière de Tubize SA$216.20+2.95%ICY.FIncyte Corporation$110.35-4.38%IUI1.FIntuitive Surgical, Inc.$303.00-2.38%HDP1.FArrowhead Pharmaceuticals, Inc.$75.60+0.80%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy